Sign inJoin waitlistJoin the waitlist

Marie Bleakley

Co-Director, HRL Program, Pediatric HCT Physician with Leukemia/Lymphoma HCT Expertise · University of Washington School of Medicine

Credentials: · · ·

History

HRL Program · University of Washington School of Medicine
Present
High-Risk Leukemia and Lymphoma Program · University of Washington School of Medicine
Present
High Risk Leukemia Program · University of Washington School of Medicine
Present

The Children’s Hospital at Westmead
1999–2001
The University of Newcastle
2000
The Children’s Hospital at Westmead
1996–1999
The University of Sydney
FLINDERS UNIV OF S. AUSTRALIA, BEDFORD PARK, S. AUSTRALIA
1990–1994

Research

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
Blood · 2017 · 965 citations
Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of…
Blood · 2007 · 391 citations
Molecules and mechanisms of the graft-versus-leukaemia effect
Nature reviews. Cancer · 2004 · First of 2 authors · 310 citations

Stanley Riddell
16 papers
Melinda Biernacki
15 papers
Corinne Summers
10 papers
Ann Dahlberg
9 papers
CT
Cameron Turtle
7 papers
Paul Carpenter
7 papers
Monica Thakar
6 papers
Aude Chapuis
5 papers
David Maloney
5 papers
Derek Stirewalt
5 papers
Edus Warren
5 papers
Joachim Deeg
5 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $659.6K · Fred Hutchinson Cancer Center
1997–2029
Development of Innovative Resources to Advance MDS Research
National Institute of Diabetes and Digestive and Kidney Diseases · RC2
Contact PI · $6.2M · Fred Hutchinson Cancer Center
2023–2028
Adult Leukemia Research Center
National Cancer Institute · P01
Project lead · $4.6M · Fred Hutchinson Cancer Center
1997–2024
Naive T Cell Depletion to Prevent Graft-Versus-Host Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.7M · Fred Hutchinson Cancer Research Center
2014–2019

Clinical trials

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Principal investigator · Recruiting · Phase 2
Fred Hutchinson Cancer Center
2019–2029
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Principal investigator · Active not recruiting · Phase 2
Fred Hutchinson Cancer Center
2019–2028
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2015–2025
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2014–2023